Additional file 1 of Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer

Additional file 1: Supplemental Table 1. Use of systemic anti-cancer treatment in patients with advanced lung cancer. Supplemental Table 2. Myelotoxicity and infectious complications in patients with and without 14- and 30-day mortality after last cycle of systemic anti-cancer treatment.